Filtered By:
Specialty: Biomedical Science
Vaccination: Covid Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 695 results found since Jan 2013.

Determinants of post discharge mortality among hospitalized COVID-19 patients: Nested matched case-control analyses from the National Clinical Registry for COVID-19
CONCLUSIONS: : Prior vaccination protects against post discharge mortality till one year in hospitalized COVID-19 patients. PCC may have long term deleterious effects, including mortality, for which further research is warranted.PMID:37675689 | DOI:10.4103/ijmr.ijmr_973_23
Source: The Indian Journal of Medical Research - September 7, 2023 Category: Biomedical Science Authors: Gunjan Kumar Arunansu Talukdar Alka Turuk Ashish Bhalla Subhasis Mukherjee Pankaj Bhardwaj Tarun Bhatnagar Aparna Mukherjee Source Type: research

Antibody titers of individuals vaccinated for COVID-19: A systematic review
J Biosci. 2023;48:32.ABSTRACTAn important preventive measure to mitigate the COVID-19 pandemic is vaccine implementation. In creating vaccines, evoking neutralizing antibody (NAb) production is the main objective. This review determines and compares the NAb titers produced by COVID-19 vaccine recipients based on the vaccine type and the manner of administration. This review includes published articles on studies with healthy participants with a minimum age of 18 years, without previous infections, and those who were given Emergency Use License (EUL) vaccines from WHO. Bias assessment was performed using the Cochrane Risk o...
Source: Journal of Biosciences - September 6, 2023 Category: Biomedical Science Authors: Aminoddin M Domado Homobono Jacob F Adaza Andrea Pauline Nicole C Beltran Leila M Buenviaje Catherine D Co Leira R Combalicer Shiela May A Corona John Benedict F Cruz Maria Adrianne Camille G Dinjotian Eli Marie S Esperanzate Shaira Reinalyn G Luna Ethelb Source Type: research

Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
Sci Signal. 2023 Aug 15;16(798):eabk3516. doi: 10.1126/scisignal.abk3516. Epub 2023 Aug 15.ABSTRACTThe emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underscores the need for strategies to rapidly develop neutralizing monoclonal antibodies that can function as prophylactic and therapeutic agents and to help guide vaccine design. Here, we demonstrate that engineering approaches can be used to refocus an existing antibody that neutralizes one virus but not a related virus. Through a rapid affinity maturation strategy, we engineered CR3022, a SARS-CoV-1-neutralizing antibody, to bind to the receptor...
Source: Science Signaling - August 15, 2023 Category: Biomedical Science Authors: Fangzhu Zhao Meng Yuan Celina Keating Namir Shaabani Oliver Limbo Collin Joyce Jordan Woehl Shawn Barman Alison Burns Quoc Tran Xueyong Zhu Michael Ricciardi Linghang Peng Jessica Smith Deli Huang Bryan Briney Devin Sok David Nemazee John R Teijaro Ian A Source Type: research